The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study.
 
David J. Straus
Consulting or Advisory Role - Seagen
Research Funding - Seagen
 
Monika Długosz-Danecka
Consulting or Advisory Role - Janssen; Roche; SERVIER
 
Sergiy Alekseev
No Relationships to Disclose
 
Árpád Illés
Research Funding - Abbvie (Inst); Novartis (Inst); Roche (Inst)
 
Marco Picardi
No Relationships to Disclose
 
Ewa Lech-Maranda
Consulting or Advisory Role - Abbvie; Amgen; Janssen-Cilag; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Amgen; Roche
 
Tatyana Feldman
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb; Kite, a Gilead company; Pharmacyclics/Janssen; Seagen; Takeda
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Seagen
Speakers' Bureau - Abbvie; Celgene; Janssen; Kite, a Gilead company; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cell Medica (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Pfizer (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); Trillium Therapeutics (Inst); Viracta Therapeutics (Inst); Viracta Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Kite, a Gilead company; Pharmacyclics; Seagen; Takeda
 
Kerry J. Savage
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck; Novartis; Seagen; Servier; Verastem
Research Funding - Roche (Inst)
 
Piotr Smolewski
Travel, Accommodations, Expenses - Roche
 
Nancy L. Bartlett
Consulting or Advisory Role - ADC Therapeutics; Pfizer; Seagen
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Andrea Gallamini
Honoraria - Takeda
 
Jan Andrzej Walewski
Honoraria - Celgene; Janssen-Cilag; Roche; Servier; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen-Cilag; Roche
Research Funding - GlaxoSmithKline/Novartis (Inst); Janssen-Cilag (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Rod Ramchandren
Consulting or Advisory Role - Bristol-Myers Squibb; Pharmacyclics/Janssen; Sandoz-Novartis; Seagen
Research Funding - Genentech (Inst); Janssen (Inst); Merck (Inst); Seagen (Inst)
 
Pier Luigi Zinzani
Honoraria - Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; SERVIER
 
Joseph M. Connors
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cephalon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Roche (Inst); Seagen (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Evaluation of mantle cell lymphoma and methods related thereof (Inst); Methods for selecting and treating lymphoma types (Inst)
 
Hina Jolin
Employment - Takeda
 
Rachael Liu
Employment - Takeda
 
Keenan Fenton
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Michelle Fanale
Employment - Seagen
Stock and Other Ownership Interests - Seagen
Research Funding - ADC Therapeutics; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; MedImmune; Merck; Molecular Templates; Takeda
Travel, Accommodations, Expenses - Spectrum Pharmaceuticals
 
John A. Radford
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline
Honoraria - Takeda
Consulting or Advisory Role - ADC Therapeutics; Takeda
Speakers' Bureau - Gilead Sciences; Takeda
Research Funding - ADC Therapeutics (Inst); Kite, a Gilead company (Inst)
Travel, Accommodations, Expenses - ADC Therapeutics; Takeda